These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25004087)

  • 1. Pharmacological approaches to coronary microvascular dysfunction.
    Guarini G; Huqi A; Morrone D; Capozza P; Todiere G; Marzilli M
    Pharmacol Ther; 2014 Dec; 144(3):283-302. PubMed ID: 25004087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Coronary microvascular disease: from experimental models to clinical practice].
    Vecoli C; Caselli C; Caruso R; Morales MA
    Recenti Prog Med; 2012; 103(7-8):288-96. PubMed ID: 22825385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention with vasoactive drugs].
    Motz W; Vogt M; Scheler S; Schwartzkopff BE; Kelm M; Strauer BE
    Z Kardiol; 1992; 81 Suppl 4():199-204. PubMed ID: 1290299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary microcirculation in hypertensive heart disease: functional significance and therapeutic implications.
    Motz W; Vogt M; Strauer BE
    Clin Investig; 1993; 71(5 Suppl):S42-5. PubMed ID: 8518540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No reflow phenomenon in coronary heart disease.
    Ito H
    J Cardiol; 2001; 37 Suppl 1():39-42. PubMed ID: 11433826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New drug (Sensit) for the treatment of coronary disease in a double blind test].
    Pillen D
    Fortschr Med; 1974 Jun; 92(16):709-11. PubMed ID: 4600940
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension and microvascular angina].
    Vogt M; Motz W; Strauer BE
    Arzneimittelforschung; 1994 Dec; 44(12):1321-8. PubMed ID: 7848351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coronary artery disease].
    Watanabe Y; Daida H
    Nihon Rinsho; 2003 Jul; 61(7):1181-6. PubMed ID: 12877082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ protection: benefit from antihypertensive treatment?
    Motz W; Strauer BE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S50-4. PubMed ID: 7898094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between coronary microvascular function and angina status in patients with stable microvascular angina.
    Di Franco A; Villano A; Di Monaco A; Lamendola P; Russo G; Stazi A; Scavone G; Nerla R; Sestito A; Lanza GA; Crea F
    Eur Rev Med Pharmacol Sci; 2014; 18(3):374-9. PubMed ID: 24563437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coronary microangiopathy in hypertensive heart disease: pathogenesis, diagnosis and therapy].
    Motz W; Scheler S; Strauer BE
    Herz; 1995 Dec; 20(6):355-64. PubMed ID: 8582695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary microvascular dysfunction in patients with diabetes, hypertension and metabolic syndrome.
    Sucato V; Novo G; Evola S; Novo S
    Int J Cardiol; 2015; 186():96-7. PubMed ID: 25814352
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach.
    Jaffe R; Dick A; Strauss BH
    JACC Cardiovasc Interv; 2010 Jul; 3(7):695-704. PubMed ID: 20650430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings.
    Pries AR; Habazettl H; Ambrosio G; Hansen PR; Kaski JC; Schächinger V; Tillmanns H; Vassalli G; Tritto I; Weis M; de Wit C; Bugiardini R
    Cardiovasc Res; 2008 Nov; 80(2):165-74. PubMed ID: 18511433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coronary microcirculation. Pathophysiology, clinical relevance, and importance for regenerative therapy after myocardial infarction].
    Schächinger V; Zeiher AM
    Herz; 2005 Nov; 30(7):641-50. PubMed ID: 16333592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy.
    Brush JE; Cannon RO; Schenke WH; Bonow RO; Leon MB; Maron BJ; Epstein SE
    N Engl J Med; 1988 Nov; 319(20):1302-7. PubMed ID: 3185633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary vasoconstriction: where do we stand in 1999. An important, multifaceted but elusive role.
    Maseri A; Crea F; Lanza GA
    Cardiologia; 1999 Feb; 44(2):115-8. PubMed ID: 10208047
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological approaches to the therapy of angina.
    Parratt JR
    Adv Drug Res; 1974; 9():103-34. PubMed ID: 4156950
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of malate and NAD for the correction of the blood supply and oxygen balance of the acutely ischemic myocardium].
    Kostin VI
    Farmakol Toksikol; 1986; 49(3):44-6. PubMed ID: 3720933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-relationships between hypertension, left ventricular hypertrophy and coronary heart disease.
    Devereux RB; Roman MJ
    J Hypertens Suppl; 1993 Jun; 11(4):S3-9. PubMed ID: 8377033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.